Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Medford

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Acta Neuropathologica|January 22, 2003
Synphilin in normal human brains and in synucleinopathies: studies with new antibodiesIan J Murray, Marlon A Medford, Hong-Ping Guan, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 8, 2014
Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patientsBeth A Medford, Nathaniel W Taggart, Allison K Cabalka, et al.
Agents and Actions|July 1, 1981
Ro 21-7634, a new antiallergic agent with potent oral activityR A Salvador, L B Czyzewski, H Baruth, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Acta Neuropathologica|January 22, 2003
Synphilin in normal human brains and in synucleinopathies: studies with new antibodiesIan J Murray, Marlon A Medford, Hong-Ping Guan, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|July 8, 2014
Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patientsBeth A Medford, Nathaniel W Taggart, Allison K Cabalka, et al.
Agents and Actions|July 1, 1981
Ro 21-7634, a new antiallergic agent with potent oral activityR A Salvador, L B Czyzewski, H Baruth, et al.
Pageof 2